The Healthcare Information and Management Systems Society (Chicago) has named four new officers and four new members of the HIMSS Board of Directors, who took office on July 1.

Barry P. Chaiken, M.D., M.P.H., FHIMSS, assumed the one-year term as chair of the board, replacing Chuck Christian, CIO and director of information systems at Good Samaritan Hospital (Vincennes, Ind.). Liz Johnson, R.N., M.S., CPHIMS, FHIMSS, started her second term as vice chair.

Chaiken serves as chief medical officer at DocsNetwork Ltd., a company he founded. In his new position, Chaiken hopes to examine payers’ involvement in advancing the use of IT and management systems to improve patient care. He also says he wants to explore how life science professionals can participate in leading healthcare transformation through health IT.

Johnson is vice president of applied clinical informatics for Tenet Healthcare Corp. Her responsibilities include establishing the strategic vision and operations plan for provision of clinical systems used throughout the 52-hospital provider organization.

Beginning their three-year terms, the Society’s four new board members include: R. Scott Holbrook, M.S., FHIMSS, executive vice president, Medicity; Willa Fields, DNSc, R.N., FHIMSS, associate professor, San Diego State University; Jenifer Jarriel, MBA, vice president of IT and CIO, Baylor College of Medicine; and Miriam Paramore, FHIMSS, senior vice president, corporate strategy and public relations, Emdeon.

The following individuals began their two-year term on the Nominating Committee: Drexel Deford, FHIMSS, senior vice president and CIO, Seattle Children’s Hospital and Regional Medical Center; Mark Jacobs, MHA, CPHIMS, FHIMSS, director, technology services, WellSpan Health; and Robin Raiford, RN-BC, CPHIMS, FHIMSS, director, government initiatives, Eclipsys Corp.

The two new Advisory Board Members are Kevin Hayden, senior vice president and president, state sponsored business, WellPoint Inc.; and Deb Bremer, vice president of oncology business technology, Pfizer Inc.